This study measured the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes.
Satyin Kaura, MSci, MBA
Advertisement
Articles by Satyin Kaura, MSci, MBA
Advertisement
Latest Updated Articles
- The Value of Survival Gains in Myelodysplastic Syndromes
Published: January 16th 2017 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells
2
Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms
3
Mediterranean Diet Improves Psoriasis Severity, Study Finds
4
FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years
5
